Have worms lost their luster?
- PMID: 23429450
- PMCID: PMC4129650
- DOI: 10.1097/MIB.0b013e318281d35b
Have worms lost their luster?
Abstract
Childhood infections with some helminths have been reported to reduce the risk of acquiring some immune-mediated diseases like sensitization to allergens, asthma and inflammatory bowel disease. Denmark keeps a medical registry that collects data on disease prevalence and medication use throughout the country. Mebendazole frequently is used to treat pinworm (Enterobius vermicularis) infection. In this population-based analysis of a cohort of 924,749 children, prescriptions for Mebendazole were used as a surrogate marker for pinworm infection. Children who received this medication were compared to children who did not, for the frequency of asthma, type I diabetes, juvenile arthritis, ulcerative colitis and Crohn’s disease. It was found that Mebendazole use, and by inference pinworm infection, did not appear to reduce the risk for acquiring any of these immune-mediated diseases.
Comment on
-
Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study.Gastroenterology. 2012 Jan;142(1):55-62. doi: 10.1053/j.gastro.2011.09.046. Epub 2011 Oct 6. Gastroenterology. 2012. PMID: 21983081
References
-
- Elliott DE, Urban JF, Jr, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn’s disease? FASEB J. 2000;14:1848–1855. - PubMed
-
- Bager P, Vinkel HA, Wohlfahrt J, Melbye M. Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology. 2012;142:55–62. - PubMed
-
- Otu-Bassey IB, Ejezie GC, Epoke J, Useh MF. Enterobiasis and its relationship with anal itching and enuresis among school-age children in Calabar, Nigeria. Annals of Tropical Medicine & Parasitology. 2005;99:611–616. - PubMed
-
- Kabeerdoss J, Pugazhendhi S, Subramanian V, Binder HJ, Ramakrishna BS. Exposure to hookworms in patients with Crohn’s disease: a case-control study. Alimentary Pharmacology & Therapeutics. 2011;34:923–930. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources